{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:31Z","timestamp":1787009971764,"version":"build-2736575974"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T00:00:00Z","timestamp":1654992000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Gut dysbiosis contributes to multiple autoimmune diseases, including ankylosing spondylitis, which is commonly treated with tumor necrosis factor (TNF)-\u03b1 inhibitors (TNFis). Because host TNF-\u03b1 levels are considered to interact with gut microbiota, we aimed to systematically investigate the microbiota profile of ankylosing spondylitis patients with anti-TNF-\u03b1-based treatment and identify potential key bacteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Fecal samples were collected from 11 healthy controls and 24 ankylosing spondylitis patients before\/after anti-TNF-\u03b1 treatment, the microbiota profiles of which were evaluated by 16S ribosomal DNA amplicon sequencing and subsequent bioinformatic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Significantly different microbial compositions were observed in samples from ankylosing spondylitis patients compared with healthy controls, characterized by a lower abundance of short-chain fatty acid (SCFA)-producing bacteria. All patients exhibited a positive response after anti-TNF-\u03b1 treatment, accompanied by a trend of restoration in the microbiota compositions and functional profile of ankylosing spondylitis patients to healthy controls. In particular, the abundance of SCFA-producing bacteria (e.g.\n                      <jats:italic toggle=\"yes\">Megamonsa<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Lachnoclostridium<\/jats:italic>\n                      ) was not only significantly lower in ankylosing spondylitis patients than in healthy controls and restored after anti-TNF-\u03b1 treatment but also negatively correlated with disease severity (e.g.\n                      <jats:italic toggle=\"yes\">cor<\/jats:italic>\n                      \u2009=\u2009-0.52,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20098\u2009\u00d7\u200910\n                      <jats:sup>\u22125<\/jats:sup>\n                      for\n                      <jats:italic toggle=\"yes\">Megamonsa<\/jats:italic>\n                      ). In contrast,\n                      <jats:italic toggle=\"yes\">Bacilli<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Haemophilus<\/jats:italic>\n                      may contribute to ankylosing spondylitis onset and severity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Microbiota dysbiosis in ankylosing spondylitis patients can be restored after anti-TNF-\u03b1 treatment, possibly by impacting SCFA-producing bacteria.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/fpc.0000000000000468","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T12:09:52Z","timestamp":1658232592000},"page":"247-256","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Association of anti-TNF-\u03b1 treatment with gut microbiota of patients with ankylosing spondylitis"],"prefix":"10.1097","volume":"32","author":[{"given":"Qinghong","family":"Dai","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China"},{"name":"Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Xiangya Hospital, Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjia","family":"He","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Xiangya Hospital, Central South University, Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibing","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,12]]},"reference":[{"key":"R1-20250808","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis.","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"key":"R2-20250808","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s10067-006-0488-7","article-title":"Ankylosing spondylitis is linked to Klebsiella\u2013the evidence.","volume":"26","author":"Rashid","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R3-20250808","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semarthrit.2007.01.003","article-title":"Epidemiology of spondyloarthritis in the People\u2019s Republic of China: review of the literature and commentary.","volume":"37","author":"Ng","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"R4-20250808","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1186\/ar2368","article-title":"Rheumatic diseases in China.","volume":"10","author":"Zeng","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"R5-20250808","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrrheum.2015.133","article-title":"Genetics of ankylosing spondylitis\u2013insights into pathogenesis.","volume":"12","author":"Brown","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"R6-20250808","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.2667","article-title":"Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.","volume":"45","author":"Cortes","year":"2013","journal-title":"Nat Genet"},{"key":"R7-20250808","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.38967","article-title":"Brief report: intestinal dysbiosis in ankylosing spondylitis.","volume":"67","author":"Costello","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R8-20250808","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/BOR.0000000000000239","article-title":"Subclinical gut inflammation in ankylosing spondylitis.","volume":"28","author":"Ciccia","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"R9-20250808","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/annrheumdis-2012-202135","article-title":"Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive model.","volume":"72","author":"Van Praet","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R10-20250808","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ng.3528","article-title":"Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci.","volume":"48","author":"Ellinghaus","year":"2016","journal-title":"Nat Genet"},{"key":"R11-20250808","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nature11582","article-title":"Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.","volume":"491","author":"Jostins","year":"2012","journal-title":"Nature"},{"key":"R12-20250808","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrg3502","article-title":"Genetic insights into common pathways and complex relationships among immune-mediated diseases.","volume":"14","author":"Parkes","year":"2013","journal-title":"Nat Rev Genet"},{"key":"R13-20250808","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.immuni.2018.11.016","article-title":"Perinatal Interactions between the Microbiome, Immunity, and Neurodevelopment.","volume":"50","author":"Pronovost","year":"2019","journal-title":"Immunity"},{"key":"R14-20250808","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaut.2017.03.009","article-title":"Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.","volume":"83","author":"Chen","year":"2017","journal-title":"J Autoimmun"},{"key":"R15-20250808","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/j.gastro.2016.10.012","article-title":"Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches.","volume":"152","author":"Sartor","year":"2017","journal-title":"Gastroenterology"},{"key":"R16-20250808","doi-asserted-by":"crossref","first-page":"e00176","DOI":"10.1128\/mSystems.00176-18","article-title":"Altered bacterial-fungal interkingdom networks in the guts of ankylosing spondylitis patients.","volume":"4","author":"Li","year":"2019","journal-title":"mSystems"},{"key":"R17-20250808","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13059-017-1271-6","article-title":"Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis.","volume":"18","author":"Wen","year":"2017","journal-title":"Genome Biol"},{"key":"R18-20250808","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1084\/jem.180.6.2359","article-title":"The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats.","volume":"180","author":"Taurog","year":"1994","journal-title":"J Exp Med"},{"key":"R19-20250808","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","article-title":"Pathogenesis of ankylosing spondylitis - recent advances and future directions.","volume":"13","author":"Ranganathan","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"R20-20250808","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jbspin.2015.10.015","article-title":"Trafficking of antigens from gut to sacroiliac joints and spine in reactive arthritis and spondyloarthropathies: mainly through lymphatics?","volume":"83","author":"Berthelot","year":"2016","journal-title":"Joint Bone Spine"},{"key":"R21-20250808","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrmicro2540","article-title":"Unravelling the effects of the environment and host genotype on the gut microbiome.","volume":"9","author":"Spor","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"R22-20250808","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1002\/art.30558","article-title":"Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome.","volume":"63","author":"Rosenbaum","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R23-20250808","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/art.40183","article-title":"Intestinal metabolites are profoundly altered in the context of HLA-B27 expression and functionally modulate disease in a rat model of spondyloarthritis.","volume":"69","author":"Asquith","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R24-20250808","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/art.40405","article-title":"Effects of HLA-B27 on gut microbiota in experimental spondyloarthritis implicate an ecological model of dysbiosis.","volume":"70","author":"Gill","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R25-20250808","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R26-20250808","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/ard.2011.151563","article-title":"2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis.","volume":"70","author":"van der Heijde","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R27-20250808","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/rheumatology\/ker194","article-title":"Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years\u2013early clinical response predicts long-term outcome.","volume":"50","author":"Baraliakos","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R28-20250808","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","article-title":"TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants - past, present and future.","volume":"25","author":"Sedger","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"R29-20250808","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000289205","article-title":"The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.","volume":"11","author":"Sfikakis","year":"2010","journal-title":"Curr Dir Autoimmun"},{"key":"R30-20250808","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"R31-20250808","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","article-title":"The TNF and TNF receptor superfamilies: integrating mammalian biology.","volume":"104","author":"Locksley","year":"2001","journal-title":"Cell"},{"key":"R32-20250808","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","article-title":"Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis.","volume":"38","author":"Braun","year":"1995","journal-title":"Arthritis Rheum"},{"key":"R33-20250808","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial.","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"key":"R34-20250808","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/art.20194","article-title":"Overexpression of tumor necrosis factor causes bilateral sacroiliitis.","volume":"50","author":"Redlich","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R35-20250808","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0000000000000445","article-title":"Genetic association of primary nonresponse to anti-TNF\u03b1 therapy in patients with inflammatory bowel disease.","volume":"32","author":"De","year":"2022","journal-title":"Pharmacogenet Genomics"},{"key":"R36-20250808","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/ecco-jcc\/jjw051","article-title":"Anti-TNF therapy response in patients with ulcerative colitis is associated with colonic antimicrobial peptide expression and microbiota composition.","volume":"10","author":"Magnusson","year":"2016","journal-title":"J Crohns Colitis"},{"key":"R37-20250808","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.chom.2017.03.002","article-title":"Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction.","volume":"21","author":"Thevaranjan","year":"2017","journal-title":"Cell Host Microbe"},{"key":"R38-20250808","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1210\/clinem\/dgab014","article-title":"Novel recurrent altered genes in chinese patients with anaplastic thyroid cancer.","volume":"106","author":"Zhang","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"R39-20250808","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/gutjnl-2020-323703","article-title":"Genomic evolution and diverse models of systemic metastases in colorectal cancer.","volume":"71","author":"Chen","year":"2022","journal-title":"Gut"},{"key":"R40-20250808","doi-asserted-by":"crossref","first-page":"eabf3657","DOI":"10.1126\/sciadv.abf3657","article-title":"Characterizing dedifferentiation of thyroid cancer by integrated analysis.","volume":"7","author":"Luo","year":"2021","journal-title":"Sci Adv"},{"key":"R41-20250808","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ebiom.2018.06.029","article-title":"Induction and amelioration of methotrexate-induced gastrointestinal toxicity are related to immune response and gut microbiota.","volume":"33","author":"Zhou","year":"2018","journal-title":"EBioMedicine"},{"key":"R42-20250808","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41419-019-1963-9","article-title":"Prevotella copri is associated with carboplatin-induced gut toxicity.","volume":"10","author":"Yu","year":"2019","journal-title":"Cell Death Dis"},{"key":"R43-20250808","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/annrheumdis-2016-211064","article-title":"Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.","volume":"76","author":"Breban","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R44-20250808","doi-asserted-by":"crossref","first-page":"1785246","DOI":"10.1080\/19490976.2020.1785246","article-title":"Dysbiosis in a canine model of human fistulizing Crohn\u2019s disease.","volume":"12","author":"Maldonado-Contreras","year":"2020","journal-title":"Gut Microbes"},{"key":"R45-20250808","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1058-x","article-title":"New insights from uncultivated genomes of the global human gut microbiome.","volume":"568","author":"Nayfach","year":"2019","journal-title":"Nature"},{"key":"R46-20250808","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites.","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"R47-20250808","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/s41467-020-18262-6","article-title":"Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity.","volume":"11","author":"Yang","year":"2020","journal-title":"Nat Commun"},{"key":"R48-20250808","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jnutbio.2010.07.009","article-title":"Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils.","volume":"22","author":"Vinolo","year":"2011","journal-title":"J Nutr Biochem"},{"key":"R49-20250808","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41467-017-02490-4","article-title":"Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss.","volume":"9","author":"Lucas","year":"2018","journal-title":"Nat Commun"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T12:01:48Z","timestamp":1754654508000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,12]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000468","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,12]]}}}